U.S. states should remain the primary regulators for compounding pharmacies, rather than the U.S. Food and Drug Administration, despite a deadly fungal meningitis outbreak that has killed 32 people since September, an industry group said on Thursday
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment